Rostom, M. M., El-Zohairy, M. A., Marzouk, M. A., Berger, M. R., Schols, D., Assal, R. A., . . . Zlotos, D. P. (2024). N-(4-(Benzyloxy)-3-methoxybenzyl))adamantane-1-amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer. Archiv der Pharmazie, 358(1), . https://doi.org/10.1002/ardp.202400146
Chicago-Zitierstil (17. Ausg.)Rostom, Monica M., Mariam A. El-Zohairy, Mohamed A. Marzouk, Martin R. Berger, Dominique Schols, Reem A. Assal, Yasmine M. Mandour, Hassan Adwan, und Darius P. Zlotos. "N-(4-(Benzyloxy)-3-methoxybenzyl))adamantane-1-amine (DZH2), a Dual CCR5 and CXCR4 Inhibitor as a Potential Agent Against Triple Negative Breast Cancer." Archiv Der Pharmazie 358, no. 1 (2024). https://doi.org/10.1002/ardp.202400146.
MLA-Zitierstil (9. Ausg.)Rostom, Monica M., et al. "N-(4-(Benzyloxy)-3-methoxybenzyl))adamantane-1-amine (DZH2), a Dual CCR5 and CXCR4 Inhibitor as a Potential Agent Against Triple Negative Breast Cancer." Archiv Der Pharmazie, vol. 358, no. 1, 2024, https://doi.org/10.1002/ardp.202400146.